Lal Singh, a 28-year-old male patient with hemophilia A had lived with severe pain in his right hip joint for many years. His condition had gradually worsened, causing a noticeable limp, limb shortening, chronic pain, and significant mobility issues that were affecting his daily life.
Earlier this year, Singh underwent the successful total hip replacement using a press-fit, metal-on-poly implant at AàRūs Lifestyle Hospital in Kathmandu, Nepal. Thanks to factor VIII donated by the WFH Humanitarian Aid Program, the surgical team was able to safely manage bleeding risks during and after the operation. Now recovering well, Singh is walking comfortably has a much brighter future ahead of him.
Bhaskar Raj Pant, MD, Chief Consultant Orthopedic Joint Replacement Surgeon at the hospital, thanked the WFH for providing the hospital with a separate batch of factor for the procedure, significantly increasing its chances of success.
Several WFH programs are making a difference in Nepal—such as the WFH Path to Access to Care and Treatment (PACT) Program, the WFH Development Grant Program (DGP), and the WFH Humanitarian Aid Program. To find out more about these efforts that are changing lives, read “WFH Humanitarian Aid Program supports Nepalese NMO advocacy” by clicking here.
Almost 5 million IUs of factor were donated to Nepal through the WFH Humanitarian Aid Program in 2024, along with 430 thousand mgs of non-factor replacement therapy. Since 2015, over 39 million IUs of factor, and over 1 million mgs of non-factor replacement therapy have been donated. To find out more about the WFH Humanitarian Program, please click here.
About the WFH Humanitarian Aid Program
The WFH Humanitarian Aid Program improves the lack of access to care and treatment by providing much-needed support for people with inherited bleeding disorders in developing countries. By providing patients with a more predictable and sustainable flow of humanitarian aid donations, the WFH Humanitarian Aid Program makes it possible for patients to receive consistent and reliable access to treatment and care. None of this would be possible without the generous support of Sanofi and Sobi, our Founding Visionary Contributors; Bayer, CSL Behring and Roche, our Visionary Contributors; Grifols, our Leadership Contributor; and Takeda, our Contributor. To learn more about the WFH Humanitarian Aid Program, visit www.treatmentforall.org.